Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 07 12:45PM ET
64.63
Dollar change
+0.04
Percentage change
0.06
%
IndexS&P 500 P/E11.50 EPS (ttm)5.62 Insider Own0.22% Shs Outstand1.29B Perf Week2.78%
Market Cap81.30B Forward P/E8.81 EPS next Y7.33 Insider Trans0.37% Shs Float1.26B Perf Month11.91%
Income7.19B PEG3.09 EPS next Q1.70 Inst Own82.94% Short Float1.39% Perf Quarter12.17%
Sales363.65B P/S0.22 EPS this Y-25.53% Inst Trans2.26% Short Ratio1.90 Perf Half Y-13.18%
Book/sh59.66 P/B1.08 EPS next Y12.68% ROA2.86% Short Interest17.40M Perf Year-7.34%
Cash/sh12.97 P/C4.98 EPS next 5Y3.73% ROE9.74% 52W Range52.77 - 83.25 Perf YTD-18.15%
Dividend Est.2.53 (3.91%) P/FCF15.42 EPS past 5Y- ROI4.70% 52W High-22.37% Beta0.53
Dividend TTM2.60 (4.02%) Quick Ratio0.66 Sales past 5Y13.36% Gross Margin14.79% 52W Low22.47% ATR (14)1.68
Dividend Ex-DateOct 21, 2024 Current Ratio0.86 EPS Y/Y TTM144.48% Oper. Margin3.67% RSI (14)71.61 Volatility3.08% 2.51%
Employees300000 Debt/Eq1.12 Sales Y/Y TTM7.10% Profit Margin1.98% Recom1.96 Target Price66.14
Option/ShortYes / Yes LT Debt/Eq1.04 EPS Q/Q-4.82% Payout38.34% Rel Volume1.09 Prev Close64.59
Sales Surprise-0.19% EPS Surprise5.31% Sales Q/Q2.59% EarningsAug 07 BMO Avg Volume9.18M Price64.63
SMA209.13% SMA5010.16% SMA200-2.17% Trades Volume5,262,933 Change0.06%
Date Action Analyst Rating Change Price Target Change
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
May-30-24Initiated Robert W. Baird Neutral $61
May-07-24Downgrade TD Cowen Buy → Hold $99 → $59
May-02-24Downgrade UBS Buy → Neutral $85 → $60
May-01-24Downgrade Leerink Partners Outperform → Market Perform $87 → $60
May-01-24Downgrade Cantor Fitzgerald Overweight → Neutral
Mar-06-24Initiated Barclays Equal Weight $78
Feb-26-24Initiated Leerink Partners Outperform $88
Dec-22-23Initiated HSBC Securities Buy $94
Sep-19-23Upgrade Evercore ISI In-line → Outperform $81 → $83
Today 09:00AM
06:00AM
Oct-06-24 12:46PM
07:45AM
Oct-05-24 11:09AM
04:40PM Loading…
Oct-04-24 04:40PM
01:37PM
01:07PM
10:35AM
07:09AM
06:53AM
06:33AM
05:00AM
Oct-03-24 05:45PM
03:56PM
03:27PM Loading…
03:27PM
11:00AM
09:38AM
09:00AM
Oct-02-24 06:48PM
01:59PM
11:54AM
06:42AM
05:30AM
Oct-01-24 05:09PM
04:59PM
04:38PM
04:32PM
02:39PM
02:13PM
12:37PM Loading…
12:37PM
12:36PM
12:06PM
11:48AM
11:46AM
11:00AM
09:41AM
09:36AM
08:24AM
08:12AM
08:10AM
08:04AM
08:00AM
07:27AM
04:35AM
12:01AM
Sep-30-24 07:36PM
07:02PM
07:02PM
06:01PM
05:33PM
03:44PM
03:32PM
02:40PM
02:11PM
01:48PM
01:48PM
01:23PM
12:00PM
11:30AM
09:57AM
08:55AM
08:22AM
Sep-29-24 07:26PM
Sep-27-24 09:00AM
Sep-26-24 06:00AM
Sep-25-24 05:45PM
01:35PM
12:56PM
09:00AM
Sep-24-24 03:45PM
05:50AM
Sep-23-24 04:22PM
09:58AM
Sep-22-24 07:45AM
Sep-20-24 05:20PM
04:54PM
04:54PM
04:06PM
03:26PM
Sep-19-24 05:45PM
02:09PM
11:02AM
05:19AM
04:48AM
Sep-18-24 08:00AM
Sep-16-24 09:30AM
07:52AM
06:00AM
Sep-13-24 05:45PM
Sep-12-24 09:00AM
09:00AM
Sep-10-24 03:43PM
09:29AM
Sep-06-24 11:31AM
06:15AM
Sep-05-24 04:48PM
12:55PM
Sep-02-24 06:05PM
09:05AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUDWIG EDWARD JDirectorMay 02 '24Buy53.881,00053,87921,630May 02 04:31 PM
Mahoney Michael FDirectorMay 02 '24Buy54.499,181500,2949,356May 02 04:30 PM
Shah Prem SEVP and Pres-Pharm, Consumer WFeb 16 '24Sale76.9529,4732,267,94739,765Feb 16 06:46 PM
LUDWIG EDWARD JDirectorNov 03 '23Buy70.472,000140,93020,630Nov 06 10:59 AM